uMed
PrivateLast Round
Series A
Jul 5, 2023
Total Funding Raised
$17.25M
Momentum Score
25 /100
Company Overview
uMed is a health and research technology company that provides a platform to automate clinical study processes and connect healthcare providers with research programs.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Healthcare Analytics, Patient Engagement, EHR & EMR
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting, Subscription SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
uMed Comps
Public and private peers based on sector, stage, and business model.
uMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 5, 2023 | ||||
| Seed | Nov 30, 2020 |
uMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Playfair Capital | Seed, Series A |
| Albion Capital | Series A, Seed |
| Delin Ventures | Seed, Series A |
| 11.2 Capital | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Access-PD Parkinson's Disease research cohort is active.
- Oct 1, 2025
Network now includes over 6.5 million patients across UK and US.
uMed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about uMed's valuation, stock price, and market status.
